Tissue-resident memory T cells (Trm) contribute to local immune responses and disease recurrence in psoriasis (PSO). This study investigated the phenotype and function of CD8 T cells with a Trm-related phenotype in blood and skin samples from PSO patients and assessed their response to anti-IL-23 therapy. Circulating CLA+CD49a+ CD8 T cells were expanded in PSO compared with healthy controls and other inflammatory diseases. In skin, CD49a+ Trm subsets correlated with disease severity (psoriasis area severity index [PASI]). Functionally, CD49a expression was associated with IFNγ production, whereas CD103 identified IL17- and IL22-producing cells. A triple-positive CLA+CD103+CD49a+ subset was enriched in IL17+IL22+ cells and positively correlated with disease severity, suggesting a pathogenic role. Treatment with Tildrakizumab significantly reduced CLA+CD49a+ Trm cells, particularly the triple-positive subset, along with IL17+IL22+ cells. In contrast, CLA-CD49a+ cells persisted despite clinical remission, indicating a potential role in disease memory and relapse. Overall, the findings highlight the functional heterogeneity of CD8 Trm cells in PSO and identify distinct subsets associated with inflammation, therapeutic response, and disease persistence, supporting Trm cells as potential targets for more durable treatments.
CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy / Sartori, G., Cammarata, I., Lopardo, R., Pacella, I., Cipriano, E., Ceccarelli, F., Marraffa, F., Conti, F., Rizzuto, G., Carlesimo, D., Dattola, A., Richetta, A.G., Piconese, S.. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - 56:11(2026). [10.1002/eji.70324]
CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy
Sartori, Giorgia;Cammarata, Ilenia;Lopardo, Rossella;Pacella, Ilenia;Cipriano, Enrica;Ceccarelli, Fulvia;Marraffa, Federica;Conti, Fabrizio;Rizzuto, Giuseppe;Carlesimo, Davide;Dattola, Annunziata;Richetta, Antonio Giovanni
;Piconese, Silvia
2026
Abstract
Tissue-resident memory T cells (Trm) contribute to local immune responses and disease recurrence in psoriasis (PSO). This study investigated the phenotype and function of CD8 T cells with a Trm-related phenotype in blood and skin samples from PSO patients and assessed their response to anti-IL-23 therapy. Circulating CLA+CD49a+ CD8 T cells were expanded in PSO compared with healthy controls and other inflammatory diseases. In skin, CD49a+ Trm subsets correlated with disease severity (psoriasis area severity index [PASI]). Functionally, CD49a expression was associated with IFNγ production, whereas CD103 identified IL17- and IL22-producing cells. A triple-positive CLA+CD103+CD49a+ subset was enriched in IL17+IL22+ cells and positively correlated with disease severity, suggesting a pathogenic role. Treatment with Tildrakizumab significantly reduced CLA+CD49a+ Trm cells, particularly the triple-positive subset, along with IL17+IL22+ cells. In contrast, CLA-CD49a+ cells persisted despite clinical remission, indicating a potential role in disease memory and relapse. Overall, the findings highlight the functional heterogeneity of CD8 Trm cells in PSO and identify distinct subsets associated with inflammation, therapeutic response, and disease persistence, supporting Trm cells as potential targets for more durable treatments.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


